582 related articles for article (PubMed ID: 24668538)
1. Pulmonary manifestations of polymyositis/dermatomyositis.
Hallowell RW; Ascherman DP; Danoff SK
Semin Respir Crit Care Med; 2014 Apr; 35(2):239-48. PubMed ID: 24668538
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary manifestations of the idiopathic inflammatory myopathies.
Kalluri M; Oddis CV
Clin Chest Med; 2010 Sep; 31(3):501-12. PubMed ID: 20692542
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
[No Abstract] [Full Text] [Related]
4. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary complications of polymyositis and dermatomyositis.
Fathi M; Lundberg IE; Tornling G
Semin Respir Crit Care Med; 2007 Aug; 28(4):451-8. PubMed ID: 17764062
[TBL] [Abstract][Full Text] [Related]
6. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
7. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease.
Cobo-Ibáñez T; López-Longo FJ; Joven B; Carreira PE; Muñoz-Fernández S; Maldonado-Romero V; Larena-Grijalba C; Cubas IL; Muriel ET; Mateos CB; de la Peña Lefebvre PG; Gomez-Gomez A; Nogal LB; Pérez A; Almodovar R; Lojo L; Ruiz-Gutiérrez L; López-Robledillo JC; García de Yébenes MJ; Nuño-Nuño L
Clin Rheumatol; 2019 Mar; 38(3):803-815. PubMed ID: 30392161
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic inflammatory myopathies from the viewpoint of rheumatologists].
Gono T; Katsumata Y; Kawaguchi Y
Brain Nerve; 2013 Nov; 65(11):1275-82. PubMed ID: 24200605
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of HRCT in myositis-associated interstitial lung disease.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Aihara K; Ikezoe K; Watanabe K; Taguchi Y; Hatta K; Oga T; Chin K; Nagai S; Mimori T; Mishima M
Respir Med; 2013 May; 107(5):745-52. PubMed ID: 23485097
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study.
Nakazawa M; Kaneko Y; Takeuchi T
Clin Rheumatol; 2018 Mar; 37(3):765-771. PubMed ID: 28975463
[TBL] [Abstract][Full Text] [Related]
12. [Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis].
Antelava OA; Khelkovskaia-Sergeeva AN; Tarasova GM; Nikishina NIu; Lopatina NE; Pal'shina SG; Fedina TP; Sazhina EG
Ter Arkh; 2014; 86(5):109-15. PubMed ID: 25026812
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis.
Trăilă D; Mlădinescu OF; Oancea C; Tudorache V
Pneumologia; 2015; 64(2):37-40. PubMed ID: 26506673
[TBL] [Abstract][Full Text] [Related]
14. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J
Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786
[TBL] [Abstract][Full Text] [Related]
15. Antisynthetase syndrome: not just an inflammatory myopathy.
Chatterjee S; Prayson R; Farver C
Cleve Clin J Med; 2013 Oct; 80(10):655-66. PubMed ID: 24085811
[TBL] [Abstract][Full Text] [Related]
16. Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man.
Aoun NY; Velez E; Aggarwal A; Hayes GB; Kenney LA
Respir Care; 2004 Dec; 49(12):1515-21. PubMed ID: 15571643
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
[TBL] [Abstract][Full Text] [Related]
19. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary involvement in polymyositis and dermatomyositis].
Tillie-Leblond I; Colin G; Lelong J; Cadranel J
Rev Mal Respir; 2006 Dec; 23(6):671-80. PubMed ID: 17202971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
